Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare Accredits GenUs to Use CodeLink Platform for Gene-Expression Service

NEW YORK, Nov. 18 (GenomeWeb News) - GE Healthcare accredited GenUs BioSystems to provide gene-expression services using the conglomerate's CodeLink platform, a GenUs spokesperson said today.


GenUs "is the only certified CodeLink laboratory focused solely on gene expression experimentation," said Jeff Bergau, a spokesperson for GenUs.


The company will use CodeLink for both gene expression and "DNA-based" experiments, according to a GenUs statement.


Scott Magnuson, president of GenUs, helped develop the CodeLink technology while he was head of genomics and bioinformatics for Motorola Life Sciences. He later left the company after it was bought by Amersham to begin GenUs in April, 2003, according to BioArray News, a GenomeWeb New publication.


The CodeLink platform became the property of GE Healthcare when the company acquired Amersham in April.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.